Alnylam Pharmaceuticals (ALNY) Financial Statistics

Biotech

Alnylam Pharmaceuticals (ALNY) company statistics: SEC fundamentals, valuation, and sector peers, each value linked to its source dataset. Its market cap was $41.5B as of 2026-07-02.

Key metrics at a glance

Market Cap

$41.5B

as of 2026-07-02

Per Share

Per-share earnings and the share count, split-adjusted to today's basis.

Metric	Latest	Period	Source
Shares Outstanding	132.6M	as of Feb 2026	SEC EDGAR

Valuation & Market

Share price and market-based valuation, derived from adjusted prices and TTM earnings.

Metric	Latest	Period	Source
Share Price (adjusted)	$312.78	as of 2026-07-02	Market data
Market Cap	$41.5B	as of 2026-07-02	SEC EDGAR

Biotech peers

Covered same-sector companies on autario, compared on the latest verified figures.

Market Cap #2 of 3 biotech companies covered

Vertex Pharmaceuticals (VRTX)	$134B
Alnylam Pharmaceuticals (ALNY)	$41.5B
Insmed Incorporated (INSM)	$24.2B

Sector median: $41.5B

Use this data programmatically

# Alnylam Pharmaceuticals datasets (JSON, no signup)
curl "https://autario.com/api/v1/public/markets/ALNY/datasets"

# Company snapshot (MCP, for LLMs like Claude or ChatGPT)
get_company_snapshot("ALNY")

Financial data from SEC EDGAR filings and split-adjusted market prices, aggregated and verified on autario.com. Each value links to its source dataset. Open this profile on autario.com.